Pharmabiz

EMA committee recommends approval of Alexion’s Klygefa to treat adults with generalised myasthenia gravis

EMA committee recommends approval of Alexion’s Klygefa to treat adults with generalised myasthenia gravis: Cambridge, UK Monday, September 21, 2026, 10:00 Hrs [IST] Alexion, Ast ...
Pharmabiz

RISE Health Innovation Summit 2026 Brings the Global Healthcare Conversation to Hyderabad on September 24

RISE Health Innovation Summit 2026 Brings the Global Healthcare Conversation to Hyderabad on September 24: Our Bureau, Bengaluru Monday, September 21, 2026, 09:00 Hrs [IST] Health ...
Pharmabiz

TN govt sanctions 735 new pharmacy seats; upgrades D.Pharm to B.Pharm in major sector overhaul

TN govt sanctions 735 new pharmacy seats; upgrades D.Pharm to B.Pharm in major sector overhaul: Peethaambaran Kunnathoor, Chennai Monday, September 21, 2026, 08:00 Hrs [IST] Follo ...
Pharmabiz

DGFT proposes new non-preferential origin rules for pharma exports and imports to boost trade

DGFT proposes new non-preferential origin rules for pharma exports and imports to boost trade: Shardul Nautiyal, Mumbai Monday, September 21, 2026, 08:00 Hrs [IST] The Directorate ...
Pharmabiz

DTAB proposes amendment to NDCT Rules to bring on GMP requirements for trial batch manufacturing

DTAB proposes amendment to NDCT Rules to bring on GMP requirements for trial batch manufacturing: Gireesh Babu, New Delhi Monday, September 21, 2026, 08:00 Hrs [IST] The Drugs Tec ...
Pharmabiz

Academia calls for faculty upskilling & biosimilar simulation labs to address industry-curricula skill gap

Academia calls for faculty upskilling & biosimilar simulation labs to address industry-curricula skill gap: Nandita Vijayasimha, Bengaluru Monday, September 21, 2026, 08:00 Hrs [I ...
Pharmabiz

CDSCO mandates inclusion of DRESS syndrome as ADR in package insert of oxcarbazepine formulations

CDSCO mandates inclusion of DRESS syndrome as ADR in package insert of oxcarbazepine formulations: Gireesh Babu, New Delhi Monday, September 21, 2026, 08:00 Hrs [IST] The Central ...
Pharmabiz

Longeveron ELPIS II phase 2b trial of laromestrocel to treat hypoplastic left heart syndrome fails to meet the primary efficacy endpoint

Longeveron ELPIS II phase 2b trial of laromestrocel to treat hypoplastic left heart syndrome fails to meet the primary efficacy endpoint: Miami Saturday, September 19, 2026, 17:30 ...
Pharmabiz

Leica Biosystems advances histology workflow efficiency and traceability with new high-speed laser cassette printer

Leica Biosystems advances histology workflow efficiency and traceability with new high-speed laser cassette printer: Deer ...
Pharmabiz

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment: United Kingdom Saturday, September 19, 2026, 15:0 ...
Pharmabiz

1ST Biotherapeutics, SK Biopharmaceuticals to advance 1ST-104, a novel drug candidate for the treatment of Parkinson's disease

ST Biotherapeutics, SK Biopharmaceuticals to advance 1ST-104, a novel drug candidate for the treatment of Parkinson's disease: Yongin, South Korea Saturday, September 19, 2026, 1 ...
Pharmabiz

Flow Neuroscience launches FL-100 in US; first US FDA-approved at-home tDCS treatment for depression

Flow Neuroscience launches FL-100 in US; first US FDA-approved at-home tDCS treatment for depression: Malmö, Sweden Saturday, September 19, 2026, 16:00 Hrs [IST] Flow Neuroscienc ...